{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:17:41Z","timestamp":1790511461250,"version":"4.1.0"},"reference-count":22,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100006286","name":"Kongelig Hofbuntmager Aage Bangs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"DOI":"10.3389\/fmed.2016.00051","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T22:14:02Z","timestamp":1478816042000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["TP53 Gene Status Affects Survival in Advanced Mycosis Fungoides"],"prefix":"10.3389","volume":"3","author":[{"given":"Gitte","family":"Wooler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Ralfkiaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Mette","family":"Rahbek Gjerdrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gniadecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"issue":"31","key":"B1","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"issue":"32","key":"B2","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous Lymphoma International Consortium Study of outcome in advanced stages of Mycosis Fungoides and Sezary Syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"B3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"issue":"2","key":"B4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/leu.2014.196","article-title":"Recurrent mutations refine prognosis in chronic lymphocytic leukemia","volume":"29","author":"Baliakas","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"B5","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1182\/blood-2015-05-647578","article-title":"Presence of multiple recurrent mutations confers poor trial outcome of relapsed\/refractory CLL","volume":"126","author":"Guieze","year":"2015","journal-title":"Blood"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/leu.2014.297","article-title":"Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia","volume":"29","author":"Malcikova","year":"2015","journal-title":"Leukemia"},{"issue":"14","key":"B7","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1182\/blood-2013-11-539726","article-title":"Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia","volume":"123","author":"Rossi","year":"2014","journal-title":"Blood"},{"issue":"16","key":"B8","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/blood-2011-11-366062","article-title":"Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies","volume":"119","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"issue":"19","key":"B9","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","article-title":"Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study","volume":"120","author":"Xu-Monette","year":"2012","journal-title":"Blood"},{"issue":"26","key":"B10","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2016-02-699843","article-title":"Candidate driver genes in Sezary syndrome: frequent perturbations of genes involved in genome maintenance and DNA repair","volume":"127","author":"Woollard","year":"2016","journal-title":"Blood"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1046\/j.1523-1747.1999.00507.x","article-title":"Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas","volume":"112","author":"McGregor","year":"1999","journal-title":"J Invest Dermatol"},{"issue":"1","key":"B12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0923-1811(00)00159-6","article-title":"Early mycosis fungoides: molecular analysis for its diagnosis and the absence of p53 gene mutations in cases with progression","volume":"26","author":"Kapur","year":"2001","journal-title":"J Dermatol Sci"},{"issue":"6","key":"B13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"issue":"4","key":"B14","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1182\/blood-2014-11-611194","article-title":"Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides","volume":"126","author":"McGirt","year":"2015","journal-title":"Blood"},{"issue":"5","key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1523-1747.1998.00167.x","article-title":"Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression","volume":"110","author":"Li","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1749-6632.2001.tb03709.x","article-title":"Molecular genetics of cutaneous lymphomas","volume":"941","author":"Whittaker","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"B17","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Pimpinelli","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Ca","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"issue":"5","key":"B19","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/jid.2012.10","article-title":"MDM2 inhibitor nutlin-3a induces apoptosis and senescence in cutaneous T-cell lymphoma: role of p53","volume":"132","author":"Manfe","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"15","key":"B20","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","article-title":"Primer3 \u2013 new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"B21","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/bioinformatics\/btm091","article-title":"Enhancements and modifications of primer design program Primer3","volume":"23","author":"Koressaar","year":"2007","journal-title":"Bioinformatics"},{"issue":"9","key":"B22","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2016.00051\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T22:14:06Z","timestamp":1478816046000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmed.2016.00051\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":22,"URL":"https:\/\/doi.org\/10.3389\/fmed.2016.00051","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}